Curevac to present at the 12th international mrna health conference

TÜbingen, germany and boston, ma / accesswire / november 4, 2024 / curevac n.v. (nasdaq:cvac) ("curevac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), today announced that new and updated data will be shared in two oral presentations and four posters at the 12th international mrna health conference, taking place in boston, massachusetts, november 12-14, 2024.
CVAC Ratings Summary
CVAC Quant Ranking